Peter Varunok

1.5k citations
4 papers · 557 · 1 hit paper · h-index 4

Impact in

  • Hepatology top 1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies
    • HIV, Drug Use, Sexual Risk

Papers in

    • Hepatitis C virus research 4
    • Hepatitis B Virus Studies 3
    • Liver Disease Diagnosis and Treatment 2

Peter Varunok

4 papers receiving 548 citations

Hit Papers

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin 2014 · 395 citations
3950+4+8Years since publication100200300

Peers

Peter Varunok
Comparison fields: 5 of 40
  • Hepatology 537
  • Epidemiology 484
  • Infectious Diseases 149
  • Rheumatology 37
  • Transplantation 4
Replace D. Hueppe with:
D. Hueppe Germany
Eirum Chaudhri Japan
Tolga Baykal United States
Isabelle Lonjon‐Domanec France
Stuart Black United States
Melissa Shaughnessy United States
Bart Fevery United States
Karl‐Georg Simon Germany
Evguenia Svarovskaia United States
Mark S. Sulkowski United States
Peter Varunok relative to D. Hueppe Germany D. Hueppe's profile →
Citations per field
00.5×2.9×
D. Hueppe · 1×
Citations per year

Countries citing papers authored by Peter Varunok

Since Specialization
Citations

This map shows the geographic impact of Peter Varunok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Varunok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Varunok more than expected).

Fields of papers citing papers by Peter Varunok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Varunok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Varunok. The network helps show where Peter Varunok may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Varunok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Varunok Line = papers co-authored together Peter Varunok links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Hit paper breakdown →
2014395
2 201588
3 201568
4 20116

About Peter Varunok

Peter Varunok is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 4 papers that have together received 557 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), Hepatitis B Virus Studies (3 papers), Liver Disease Diagnosis and Treatment (2 papers), HIV/AIDS drug development and treatment (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Hepatology (537 citations), Epidemiology (484 citations), Infectious Diseases (149 citations), Rheumatology (37 citations) and Transplantation (4 citations). Peter Varunok has collaborated with scholars based in United States, France and Romania. Frequent co-authors include Edward Tam, Stefan Zeuzem, Ira M. Jacobson, Mark Sulkowski, Rui Tato Marinho, Lois Larsen, Thomas Podsadecki, Donald M. Jensen, Marc Bourlière and Adrian M. Di Bisceglie. Their work appears in journals such as Patient Preference and Adherence, Journal of Hepatology, New England Journal of Medicine and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact